Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Marijuana Abuse × 90 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 506 Neoplasms 435 Carcinoma, Non-Small-Cell Lung 351 Prostatic Neoplasms 318 Lung Neoplasms 254 Colorectal Neoplasms 237 Neoplasm Metastasis 198 Ovarian Neoplasms 172 Leukemia, Myeloid, Acute 172 Multiple Myeloma 168 Pancreatic Neoplasms 160 Stomach Neoplasms 128 Recurrence 127 Endometrial Neoplasms 123 Melanoma 122 Squamous Cell Carcinoma of Head and Neck 120 Brain Neoplasms 112 Triple Negative Breast Neoplasms 109 Carcinoma, Hepatocellular 107 Uterine Cervical Neoplasms 106 Lymphoma 102 Urinary Bladder Neoplasms 101 Precursor Cell Lymphoblastic Leukemia-Lymphoma 101 Glioblastoma 97 Head and Neck Neoplasms 92 Hematologic Neoplasms 86 Carcinoma, Renal Cell 86 Sarcoma 84 Lymphoma, Non-Hodgkin 81 Esophageal Neoplasms 77

Interventions

nabiximols 1 Temozolomide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05629702 2026-01-30

ARISTOCRAT

University of Birmingham

Phase 2 Recruiting

Brain Neoplasms, Marijuana Abuse, Glioblastoma, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡